Non-selective monoamine reuptake inhibitors

MRI_NONSEL

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N06AA

25684

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

12463

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

12463

diagram downward connector

Include endpoints None

12463

diagram downward connector
MRI_NONSEL

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 12121 8009 4112
Unadjusted prevalence (%) 3.93 4.62 3.05
Mean age at first event (years) 48.47 47.57 50.21

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.66 [1.32, 2.08] 1.3e-5 1397
15 years 0.01 1.35 [1.12, 1.63] 1.8e-3 726
5 years 0.00 1.74 [1.46, 2.08] 1.1e-9 245
1 year 0.00 1.95 [1.44, 2.64] 1.4e-5 52

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MRI_NONSEL – Non-selective monoamine reuptake inhibitors
GWS hits:

Survival analyses between endpoints

Plot

before Non-selective monoamine reuptake inhibitors
after Non-selective monoamine reuptake inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Non-selective monoamine reuptake inhibitors